clinical biochemistry assays
TRANSCRIPT
-
8/13/2019 Clinical Biochemistry Assays
1/29
PRACTICAL I
CLINICAL BIOCHEMISTRY ASSAYS
GLUCOSE
PROFILE
LIVER
FUNCTION
TEST(LFT)
KIDNEY
FUNCTION
TEST(KFT)
LIPID
PROFILE
CARDIAC
PROFILE
IRON
STUDIES
BONE
PROFIL
FBS/RBS
(FPG)
AST BUN TOTAL
CHOLES
AST TOTAL
IRON
CREAT
GTT ALT CREAT TRIG LDH TIBC ALB
2HR PP ALP Na+
HDL-C CK-MB Ferritin Ca2+
HbA1c GGT K+
LDL-C MYOGLO PO42-
URINE
sugar/ketones
TOTAL
BILIRUBIN
Cl-
VLDL TROPONIN ALP
Direct BUE Mg2+
Indirect URIC ACID
TOTAL
PROTEIN
Albumin
Globulins
CREAT
CLEAR.
1
-
8/13/2019 Clinical Biochemistry Assays
2/29
HORMONAL ASSAYS
THYROID FN
TEST
FERTILITY
HORMONES
TUMOUR
MARKERS
OTHER
HORMONES
OTHER
CHEMISTRIES
T4 FSH Total PSA INSULIN AMYLASE
T3 LH B-HCG CORTISOL
TSH PRL CEA
PRG AFP
E2 CA 125
TESTOSTERONE CA19-9 /CA15-3
SPECTROPHOTOMETRY
Measurement of light intensity of multiple wavelengths
LAMBERT-BEERS LAW: The [substance] is directly proportional to the amount of light
absorbed or inversely proportional to the logarithm of the transmitted light.
CA log 100
%T
A=abC
Where A= absorptivity, b=length of light path, C= [ ]
a and b are constants.
C1=A1, C2=A2,
C1 = A1
C2 A
2
[Ctest= CstdA test]
Astd
Beers law is the basis of all the spectrophotometric measurements.
Advantages of spectrophotometric measurements:
1. High sensitivity
2
-
8/13/2019 Clinical Biochemistry Assays
3/29
2. Ease of measurement3. High degree of specificity4. Accuracy
Urinalysis is an indispensable part of chemical pathology. It is used to uncover dx anywhere in the
urinary tract.
TESTS ON URINE COMMONLY INCLUDES
A) URINE COLOUR AND APPEARANCE (MACROSCOPY):Its colour is determined by its concentration, the presence of drugs, exogenous and endogenous
compounds and its pH.
Colourless urine---normal or 20to diuretic use, high fluid intake,DIorDM.
Cloudy/Hazy------phosphates, pyuria,or bacteruria
Yellow to orange----- presence of bile, riboflavin , bilirubin, urobilinogen
Red----------------presence of haemoglobin,
Amber
B)CHEMICAL COMPONENTS
TEST REFERENCE
Specific gravity 1.003-1.029
pH 4.5-7.8
Protein Negative
Glucose Negative
Ketones Negative
Bilirubin Negative
3
-
8/13/2019 Clinical Biochemistry Assays
4/29
Occult blood Negative
Leukocyte Negative
Nitrite Negative
Urobilinogen 0.1-1.0 EU/dL
C )MICROSCOPY COMPONENTS:
Microscopy components consists of epithelial cells, pus cells, RBCs,WBCs,casts. These are
examined microscopically.
PRACTICAL II
An essential metabolic fuel and its concentration in the blood are normally tightly controlledby the action of insulin and the counter regulatory hormones like Glucagon, cortisol, catecholamine,
and growth hormone.
[Glu] rises after meals and stabilizes at lower levels on fasting.Syno: blood sugar, FBS, FBG sugar.
Specimen: plasma: Note: whole blood taking in fluoride oxalate vacutainer.
Patient care: Pt should be fasting for 8hours-12hours prior to the test.
Source of error: blood not in fluoride oxalate tube. Glycolysis by red cells will consume glu and may
lower concentrate in vitro in absence of fluoride.
BLOOD & PLASMA GLUCOSE
Plasma [glu] is 10-15% higher than whole blood [glu] since red cells contain less water per unit
volume than plasma. The discrepancy can be greater them this if [glu] is changing rapidly because
glu will not have reached equilibration across the red cell membrane. Therefore plasma yields more
reliable results.
4
-
8/13/2019 Clinical Biochemistry Assays
5/29
Types of glucose test:
RBS, 1hr pp, 2hr pp.
2hr Postprandial: glucose levels 2hrs after meal or after measured glucose level. It is used
extensively to establish the diagnosis of DM
Ref Ranges: FBS : 3.6-6.4 mmol/L
RBS :3.3-7.0mmol/L (Dependant on time & meal content)
PRACTICAL III
GTT/OGTT
The GTT is a provocation test to examine the efficiency of the body to metabolise glucose and is
used to establish the presence of glu intolerance. It is used in pts with borderline fasting and PP glu
to support or rule out the diagnosis of DM. It is used to work up glycosuria without hyperglycemia
and also used to predict prenatal mortality in pregnancy, to diagnose gestational diabetes.
PRECAUTION BEFORE TEST
1. Pt. should fast 12 hours prior to test.
2. Pt. should not smoke due to glu stimulation by nicotine.
3. Pt should not take any drug prior to test.
4. Pt should not be stressed.
5. Pt should not eat nor drink nor smoke during test.
6. Pt should not indulge in unaccustomed amounts of exercise liking jogging.
7. Pt should be sitting up or lying over on the right side so as to facilitate rapid emptying of the
stomach.
Normal Glucose load: 75G in 300ml H2OChildren: 1.75 x weight ( up to 75g)
Pregnant women: 100g in 300ml
Take samples of Times 0. FBS 1. 1 hr pp 2. hr pp 3. 3hr pp. with urine samples H2O
GLUCOSE LOAD: g in 300 ml H2O
RESULTS OF OGTT Vs TIME
5
-
8/13/2019 Clinical Biochemistry Assays
6/29
TIME (Min)BLOOD GLUCOSE
CONC (mmol/L)URINE SUGAR
0
FASTING BLOOD
SUGAR
60
120
180
METHODOLOGY: Glucose oxidase method or Hexokinase method.
Principle of method: glucose oxidase (GOD) catalyzes the oxidation of glucose to
give hydrogen peroxide (H2O2) and gluconic acid. In the presence of enzyme
peroxidase (POD), the hydrogen peroxide is broken down and the oxygen
released reacts with 4-aminophenazone
(4-aminoantipyrine) and phenol to give a pink colour. The absorbance of the
colour produced is measured in a spectrophotometer at 520nm.
Glu+O2 + H2O Glucose + phenol + 4-G Oxidase
Aminophenazone
PROCEDURE
STD STD TEST BLK
Glucose oxidase
Rgt
1 ml 1ml 1ml 1ml
STD 10L 10L - -
TEST - - 10L -
6
-
8/13/2019 Clinical Biochemistry Assays
7/29
-
8/13/2019 Clinical Biochemistry Assays
8/29
PRACTICAL IV
TOTAL SERUM PROTEIN
1. There are over a hundred individual plasma proteins: many are present in very small
concentrations.
2. Approximately half of the total protein is albumin; much of the rest is immunoglobulins
(principally IgG)
i.e. Total Protein Albumin = Total Immunoglobulin
Ref. Range: 60 80g/LSPECIMEN: Serum ( Total plasma protein is slightly higher than total serum protein because of
coagulation factor present).
SOURCES OF ERROR:
1. Venous stasis during venipuncture can lead to increased values.
2. Haemolysis can falsely elevate (total protein)
METHODOLOGY: BIURET REACTION
PRINCIPLE: Cu2+
ions react with peptide bonds in alkaline medium to form a purple complex
which absorbs maximally at 540nm.The [ Complex] = [ protein ]
STD STD BLANK T1 T2
Biuret Rgt. 2.5mL 2.5mL 2.5mL 2.5mL 2.5mL
Std 0.05mL 0.05mL - - -
Sample - - - 0.05mL 0.05mL
Mix well and incubate at RT for 10mins and read absorbance at 540nm against rgt. blank.
Use Beers Law to calculate the [test].
ABNORMAL LEVELS OF PROTEINS CAN BE DUE TO:
HIGH LOW
1. Sarcoidiosis 1. Poor nutrition
8
-
8/13/2019 Clinical Biochemistry Assays
9/29
2. Chronic inflammation 2. Over hydration
3. Myeloma 3. Hepatic insufficiency
4. Hypergammaglobulinemia 4. Protein losing enteropathy
5. Agammaglobulinemia
ALBUMIN
The major plasma protein and is involved non-specifically in the transport of numeroussubstances including unconjugated bil, Ca
2+, free fatty acids, vitamins A, K and other
drugs.
It is the most important determinant of oncotic pressure (osmotic pressure due to ptn) andhence the distribution of fluid between the vascular and interstitial spaces.
USES:
Evaluation of nutritional status. Diagnosis of renal diseases with proteinuria. Diagnosis of chronic diseases.
SPECIMEN: Serum
Ref. Range: 35 50g/L
SOURCES OF ERROR:
1. Stasis during venipuncture can cause an apparent increase.
2. Taking blood sample close to site of intravenous infusion.
METHODOLOGY
Bromocresol Green (BCG) is widely used.
PRINCIPLE: BCG reacts with albumin in acidic medium of PH 4.2 to form a green complex
which is measured at 600nm. The reading of the complex has to be done at 30s to avoid thetendency of other proteins reacting with the BCG.
STD STD BLANK TEST TEST
BCG 2.0mL 2.0mL 2.0mL 2.0mL 2.0mL
STD 10L 10L - - -
9
-
8/13/2019 Clinical Biochemistry Assays
10/29
BLANK - - - - -
TEST - - - 10L 10L
Mix well and read absorbance at 600nm at exactly 30s. Use Beers law to calculate [test].
ABNORMAL VALUES OF ALBUMIN CAN BE DUE TO:
INCREASED CONC DECREASED CONC
1.Dehydration 1. Renal disease2. Liver insufficiency with decreased
albumin synthesis.3. Severe malnutrition4. Acute inflammation5. Chronic inflammation6. Pregnancy7. Burns
PRACTICAL V
An orange-yellow pigment, the end product of haem degradation normallymetabolized in the liver and excreted into bile.
Accumulation causes jaundice which usually become apparent when [plasma] exceedtwice normal.
Frequently elevated in Hepatobiliary dx of any type when bilirubinuria is usually alsopresent.
Differential diagnosis of liver dx requires total and direct bil values as well as othertests.
Total bil=Direct (conjugated) bil+Indirect (unconjugated) bil
Direct bil is the water soluble fraction and indirect is water insoluble.
SPECIMEN: SERUM
N.B. Protect samples from since bil is photosensitive.
Ref. Range: DBil: (< 3.4mol/l)
Total Bil: 2-21mol/l
10
-
8/13/2019 Clinical Biochemistry Assays
11/29
Neonates values vary with age in days, prematurity and maturity.
[Total bil] are measured in neonates in mol/l
AGE Premature Full term
Cord 49.6 42.8
-
8/13/2019 Clinical Biochemistry Assays
12/29
Bilirubin conc. [mg/dL] = A540x 13.0 or
[mol/L] = A540x 17.1x 13
ABNORMAL VALUES (CAUSES)
TOTAL DIRECT
1. Liver insufficiency 1. Neonatal jaundice due to atresia of bile
ducts.
2. Extra-hepatic obstruction 2. Obstructive jaundice
3. Haemolysis
4. Neonate from a variety of caused including neonatal
physiological hyperbilirubinemia.
5. Gilbert syndrome
6. Erythroblastosis fetalis
7. Dubin-Johnson syndrome
PRACTICAL VI
LIVER ENZYMES
ALKALINE PHOSPHATASE (ALP)
An enzyme occurring particularly in osteoblasts (bone-forming cells) and the liver. Plasma activities occur in various bone and Hepatobiliary disease. Measured as part of bone and liver profiles.
SPECIMEN: Serum
12
-
8/13/2019 Clinical Biochemistry Assays
13/29
Ref. Range: 53 128 U/L (in adults).
Levels up to 3x this may be normal in children.
SOURCE OF ERROR: None.
CAUSES OF ABNORMAL VALUES
Increased levels are characteristics of bone disease associated with increased osteoblastic activity
and Hepatobiliary disease with partial or complete biliary obstruction.
Increased ALP due to bone disease Increased ALP due to Hepatobiliary disease
1. Paget disease of bone 1. Cirrhosis
2. Hyperparathyroid bone dx 2. Hepatic tumours (1oand 2
o)
3. Ricketts 3. Extrahepatic biliary obstruction( eg. carcinoma of
pacreas)
4. Renal osteodystrophy
5. Healing fractures
6. Osteomalacia
7. Bone tumours (1oand 2
o)
Increased ALP can occur in late pregnancy due to secretions of the enzyme in the placenta.
Decreased ALP
1. Hypophosphotasemia
2. Hypothyroidism
3. Scurvy
PROCEDURE
Working Rgt 20mL of buffer + substrate
TEST 1 TEST 2
Sample 10L 10L
Working Rgt. 500L 500L
Mix well and read absorbance and start time simultaneously. Read again after 1,2 and 3 min [Conc.
In U/L] = 2760 x A405
13
-
8/13/2019 Clinical Biochemistry Assays
14/29
GAMMA-GLUTAMYL TRANSFERASE (GGT)
GGT is an enzyme that is mainly in the liver, often measured as part of a panel of LFT.
Increased plasma activities of GGT can occur in all types of liver disease but it is a particularly
sensitive (though not specific) indicator of excessive consumption of alcohol.
Ref. Range (12-64) U/L
SPECIMEN: Serum
CAUSES OF ABNORMAL RESULTS
Increased GGT
1. Hepatitis (alcoholic)
2. Excessive alcohol consumption
3. Cholestatic liver disease of any cause.
4. Treatment with certain anticonvulsant and other drugs.
5. Fatty liver (eg. in obesity, poorly controlled diabetes).
PRACTICAL VII
ALANINE TRANSAMINASE (ALT, GPT)
A soluble cytoplasmic enzyme widely distributed in body tissues but present in particularlyhigh amounts in the liver.
Released into the plasma when there is tissue damage (eg. Hepatitis) ALT activity is most often measured as one of LFT as a measure of hepatocellular damage
since it is more specific indicator than AST.
Parallel measurement of ALT and AST is therefore applied to distinguish liver from heart orapplied to distinguish liver from heart or skeletal muscle damages, the AST/ALT is used for
differential diagnosis in liver dx.
1 severe or chronic dx.
SPECIMEN: Serum
Ref. Range : 0 50 U/L
SOURCE OF ERROR: None
METHODOLOGY
14
-
8/13/2019 Clinical Biochemistry Assays
15/29
Enzymatic kinetic method + Enzymatic end point method.
CAUSES OF ABNORMAL RESULTS
HIGH LEVELS LOW LEVELS
1. Hepatitis 1. Renal hemodialysis or renal insufficiency
2. Cirrhosis 2. End stage of liver disease
3. Cholestatic Jaundice
4. Congestive cardiac failure (due to hepatic
congestion)
ASPARTATE TRANSAMINASE (AST/GOT)
A soluble cytoplasmic and mitochondrial enzyme widely distributed in body tissues,particularly in the liver, skeletal and cardiac muscles.
Tends to released more than ALT in chronic hepatocellular dx. e.g. cirrhosis.
SPECIMEN: Serum
SOURCES OF ERROR: Haemolysis
METHODOLOGY
Enzymatic end point reaction/ enzymatic kinetic reactions
CAUSES OF ABNORMAL TESTS:
1. Liver dx
a. Hepatitis
b. Preceded jaundice
c. Less elevation in cholestatic dx.
d. Excessive alcohol, obesity, drug toxicity, DM
2. Myocardial infarction
3. Skeletal muscle damage dx.
15
-
8/13/2019 Clinical Biochemistry Assays
16/29
PRACTICAL VIII
CREATININE
Creatinine is used to diagnose impaired renal function.
Creatinine is a catabolic product of creatinine phosphate, which is used in skeletal musclecontraction.
It is excreted entirely by the kidney s and is directly proportional to renal excretory function. Age-Related Concerns: The elderly and young children normally have lower creatinine levels
as a result of reduced muscle mass. This may potentially muscle renal dx in patients of these
age groups.
Creatinine is the most common clinical RFT providing a rough approximation of glomerularfiltration.
GFR must fall to approximately half normal before serum creatinine becomes reliablyincreased.
SPECIMEN: Serum
Ref. Ranges: Adult males: < 106mol/L
Adult females: < 97mol/L
PRINCIPLE OF THE METHOD
Creatinine reacts with picric acid in an alkaline medium. The absorbance of the yellow-red colour
produced is measured at 490nm wavelength. A number of other compounds similarly react with
picric acid giving artificially high results for creatinine if one simply measures the total yellow-red
colour produced. A second reading is therefore made after making the solution acid. The colour
produced by creatinine is quickly destroyed by acid whereas that given by non-creatinine
chromogens is destroyed more slowly. By subtracting the second reading which is due to non-
creatinine substances from the first reading (due to creatinine and non-creatinine substances) the
colour produced by the true creatinine can be obtained.
PROTOCOL
16
-
8/13/2019 Clinical Biochemistry Assays
17/29
WORKING REAGENT: EQUAL VOLUMES OF REAGENT 1 & 2
ABSORBANCE:490nm on spectrophotometer.
STD BLK TEST
WORKING RGT 1 mL 1 mL 1 mL
STD/ SAMPLE 100L - 100L
Mix well and incubate for 20seconds and read A1 at 490nm against rgt blank and incubate at room
temperature for exactly 80 seconds and read A2.
CALCULATION: [CREAT] in mol/L = 176.8 mol/L X ASAMPLE
ASTD
Increased levels
Dx affecting renal function, such as glomerulonephritis, pyleronephritis, acute tubular necrosis, U.T
obstruction, reduced renal blood flow (eg. shock, dehydration, congestive heart failure, and
atherosclerosis), diabetic nephropathy, and nephritis. Renal function impaired and creatinine
increases.
Acromegaly
Gigantism: Associated with increased muscle mass.
Decreased levels
1. Debilitation2. Decreased muscle mass (e.g. muscular dystrophy)
CREATININE CLEARANCE [CrCl]
CrCl is a measure of the GFR.Urine and serum creatinine levels are assessed and the clearance rate is calculated as :
CrCl = UV
P
U = [urine creatinine] over 24 hrs (mol/L)
V = volume of urine in mL/min= vol of urine
24 x 60
P = [serum creatinine] in mol/L.
PATIENT PREPARATION
17
-
8/13/2019 Clinical Biochemistry Assays
18/29
24 hr urine collection. Discard the initial specimen and start 24hr timing at that point.
Collect all the urine passed during the test.
Keep urine sample refrigerated.
Indicate the starting time.
Patient should drink fluids during the test.
Avoid vigorous exercise during the test.
Collect last specimen as close as possible to the end of the 24hr collection.
UREA:
urea is the major end product of nitrogen (protein) metabolism and is synthesized in the liverand excreted by the kidneys.
Urea increases in renal failure but can be increased in dehydration and in individuals on ahigh protein in take in the absence of renal impairment.
Often increased as part of renal profile i.e BUE but creatinine provides a better index of renalfunction for most purposes.
SPECIMEN: serum/plasma
REF. RANGE: 2.5-6.7mmol/l
SOURCES OF ERROR: noneMETHODOLOGY: Berthelot Reaction
Causes of abnormal results
HIGH LEVELS LOW LEVELS
1. Dehydration 1. Starvation
2. Renal failure
3. Gastrointestinal bleeding (due to catabolism of
retained blood)
4. Recent protein intake
PRACTICAL IX
18
-
8/13/2019 Clinical Biochemistry Assays
19/29
ELECTROLYTES
Sodium (Na+), Potassium (K
+) and Chloride (Cl
-)
SPECIMEN: Serum/Plasma
SOURCES OF ERROR:
Haemolysis Delay in separation of serum Dont allow patient to clench and unclench Minimal venestasis Dont force blood through needle or syringe
METHODOLOGY: Iron selective Electrode and Flame Photometry
Potassium (K+)
K+is the principal intracellular cation but its plasma concentration has a major effect on the
excitability of nerve and muscle membranes.
REF. RANGE: 3.6-5.0 mmol/l
CAUSES OF HYPOKALAEMIA
Gastroinstinal loss (diarrhoea Renal loss
Hyperkalaemia
Renal failure Accumulation of potassium supplements
Sodium (Na+)
Principal extracellular cation and determinant of extracellular fluid osmolality and volume. Abnormalities of potassium concentration can be related to abnormal water or sodium
heamostasis.
REF. RANGE: 135-145mmol/
19
-
8/13/2019 Clinical Biochemistry Assays
20/29
CAUSES OF ABNORMAL RESULTS
HYPONATREMIA HYPERNATREMIA
1. constant diuretic treatment
2. cancer
3. diarrhea and vomiting
4. congestive cardiac failure
5.chronic liver dysfunction
6.chronic renal failure
1. Dehydration
Chloride (Cl-)
The principal negatively charged ion in the ECF Provides additional diagnostic information on plasma [ Na+]Ref. range: 95-105 mmol/l
Methods used
1. Flame photometry2. Ion selective electrode (ISE)
URIC ACID
Urate is the end product of nucleic acid metabolism Increased urate can predispose of gout, due to the deposition of monosodium urate crystals in
joints.
Hyperuricaemia does not always cause gout, but gout is usually related to hyperuricaemiaSpecimen: serum (ideally fasting)
Ref. Range :( 208-428) mol/L
ABNORMAL RESULTS
Increased [urate] Decreased [urate]
20
-
8/13/2019 Clinical Biochemistry Assays
21/29
1. Gout2. Renal failure3. Diuretic therapy4. Lesch-Nyhan syndrome5. Polycystic kidney6. Leukaemia,lymphoma,polycythaemia7. Diet(high protein intake)8. Drugs(uricostatic drugs e.g. diuretic)9. Lactate excess e.g. ethanol ingestion10.Chronic lead nephropathy
1. Administration of uricosuric drugs(high doses of
salicylates,cortisone,allopurinol)
2. Renal tubular defects(Fanconissyndrome, Wilson disease)
PRACTICAL X
LIPID PROFILE
Acts as energy stores (triglyceride) and structural component.
Insoluble in water are transparent in pleasure as perimeter complexes the proteins thelipoprotein
It includes total cholesterol,triglycerides,HDL choles, LDL choles andVLDL choles
PATIENT CARE PREPARETION:
Patients should be on stable diet ideally for 2-3 weeks prior to collection of blood. Patients should fast for at least 12hours before collection of blood. Patients must abstain from alcohol at least 72hours. Posture may be a significant factor: cholesterol value may be 10% to 15% hour after 20 min
in a recumbent position. From standing to a sitting position values are about 6% hours after
20mins.
Increases of 2-5% in cholesterol may be seen if tourniquet is applied for 2mins duringsampling
21
-
8/13/2019 Clinical Biochemistry Assays
22/29
Cholesterol is the most prominent member of steroid family and is an important componentof many cell membranes
Procure of 3 major classes of steroids: steroid hormones and bile acid High serum (choles) are an important risk factor for atherosclerosis (esp. affecting the
coronary )
Serum
Sources of error: Avoid recent food intake
Ideal conc. TOTAL
4.5mmol/L (>400mg/dL).
Calculation of LDL formula
LDL= TC- (HDL+0.46trigly) mmol/l
=T C- (HDL+0.20trigly) mg/dl
Acquired [Choles]
1. Hyperthyroidism2. the cholestatic liver dx3. renal failure4. nephrotic syndrome
Inherited [Choles]
1. hypercholesterolemia2. common or polygenic hypercholesterolemia3. Hyperlipidaemia
22
-
8/13/2019 Clinical Biochemistry Assays
23/29
HDL AND LDL
The 2 principal lipoproteins which contain cholesterol are HDL and LDL. The risk of coronary
disease is associated with increased levels of LDL, while [HDL]s are inversely correlated with
risk,ie are beneficial. LDL is normally present in [high] and thus has the greater effect on total serum
cholesterol.
LDL is a major atherogenic particle and its [plasma] can therefore function as a key for
1. Identifying those with high risk of CHD2. Clinical decision making with respect to cholesterol- lowering therapy.
METHODOLOGY
The methodology for total cholesterol and HDL cholesterol.
1. TOTAL CHOLESTEROL
STD BLK TEST1 TEST 2
SAMPLE/STD 10L - 10L 10L
REAGENT/BLK 1mL 1mL 1mL 1mL
Mix well and incubate for 10mins at RT and read absorbance at 500nm.
Use Beer Lamberts Law to calculate the [test].
HDL CHOLESTEROL
The chylomicrons, VLDL and LDL are precipitated by addition of phosphotungstic acid and
MgCl2. After centrifugation, the supernatant contains HDL fraction.
Test 1 Test 2
Sample/serum 200L 200L
Precipitant 500L 500L
Mix well and incubate for 10mins at RT and centrifuge at High speed for 5mins.
Std. Blk Test 1 Test 2
Supernatant 100L - 100L 100L
Cholesterol rgt. 1mL 1mL 1mL 1mL
23
-
8/13/2019 Clinical Biochemistry Assays
24/29
Mix well and incubate at RT for 10mins and read absorbance at 500nm against rgt. blk. Use
Beers law to calculate.
LOW [HDL] can be due to
1. Obesity
2. NIDDM
3. Physical inactivity
4. Oestrogen deficiency
TRIGLYCERIDES
Triglyceride is the principal form in which energy is stored in the body. They are the majorconstituent of adipose tissue
Triglycerides circulate in the plasma as component of various lipoproteins, particularlyVLDL and chylomicron(CM)
VLDLs are made in the liver and are always present in the plasma. CM transport dietary trigfrom the gut and are not normally present in the plasma in fasting state.
SPECIMEN: Serum
Reference range:
-
8/13/2019 Clinical Biochemistry Assays
25/29
High Triglycerides Low Triglycerides
1. Inherited
a. Familial combined hyperlipidaemia (common)
b. Familial hypertriglyceridemia (uncommon)
2. Acquired
a. Drugs
b. Corticosteroids
c. DM
d. Obesity
e. Excess alcohol ingestion
PRACTICAL XI
FERTILITY HORMONES
It consists of LH, FSH, PRL, PRG, TESTO, ESTROGEN. LH and FSH are anterior-pituitary hormones which regulates male and female gonadal
function.
Measurement of FSH and LH in serum or plasma can be of value in suspected disordersof gonadal function.
SPECIMEN: Serum: For females, the LMP should be taken.
Ref. range: for females depends on the menstrual cycle thus luteal, follicular midcycle,
premenopausal and post menopausal.
SOURCE OF ERROR:
1. In pregnancy
2. In tumor secreting hCG
CAUSES OF ABNORMAL VALUES
High FSH low or normal LH = primary gonadal failure
High FSH = azoospermia, ovulatory failure.
LH > FSH = PCOS( polycystic ovary syndrome).
PROLACTIN
25
-
8/13/2019 Clinical Biochemistry Assays
26/29
A hormone secreted by the anterior pituitary which stimulates lactation and inhibitsthe action of gonadotropins.
SPECIMEN: Serum
Ref. range: Female: (1.35 24.59)ng/ml
Male: (1.5 18.75)ng/ml
SOURCES OF ERROR
1. Stress by venipuncture
2. Fasting sample
3. Draw sample between 8.00am to 10.00am.
INCREASED LEVELS
1. Hyperthyroidism
2. PCOS
3. Chronic renal failure (CRF)
4. Adenomas (micro and macro adenomas)
5. Drug treatment eg. methyldopa, oestrogen
PROGESTRONE
PRG is made by the corpus luteum. Its major source in pregnancy is the placenta.
SPECIMEN: Serum
Ref. Range: Depends upon the menstrual cycle.
OESTRADIOL
E2 is a principal female gonadal steroid and its measurements with other gonadal hormones.
It is useful in menstrual disorders.
Ref. Range: Depends on the stage of menstrual cycle.
TESTOSTERONE
26
-
8/13/2019 Clinical Biochemistry Assays
27/29
It is the major androgen responsible for sexual differentiation and male secondarysexual characteristics. It is carried in the blood by the sex hormone binding globulin
(SHBG).
SPECIMEN: SerumRef. Range:
PRACTICAL XII
TUMOUR MARKERS
Tumour markers are substances secreted into the body fluids or expressed on cellsurface which are characteristic of the presence of a tumour.
They are of potential value in screening for cancer, for diagnosis, in prognosis, inassessing the response to treatment and in long term follow up.
The most frequently used TM are substances secreted by tumours, and measuredin either in the blood or urine.
PSA
It is a glycoprotein secreted by normal prostate and [Serum] increases withincreasing age and are increased in BPH (Benign Prostatic Hypertrophy)
SPECIMEN: Serum
Ref. Range: 0 4.0ng/mL (male). Female: < 0.5
SOURCES OF ERROR
1. Constipation
2. Rectal examination 48hrs before test.
ASSAY Significance REFERENCE
-HCG
Molar pregnancy,
Choriocarcinoma,
gestational trophoblastic
(0 - 5) mlU/ml
CA 125
Cancer antigen 125Ovarian cancer (0 - 35) U/ml
27
-
8/13/2019 Clinical Biochemistry Assays
28/29
CA 15-3
Carbohydrate antigenBreast carcinoma
(0 - 37) U/ml
CA 19-9
Carbohydrate antigen
Hepatocellular
carcinoma(25 30) U/ml
CEA
Carcinoembryonic antigen
Colorectal neoplasm,
rectal(0 2.5) ng/ml
AFP
Hepatoma, teratoma,
neural tube defect(spina
bifide)
(2 16) ng/ml
PSA Prostate cancer (0 4) ng/ml
THYROID FUNCTION TEST (T3, T4, TSH)
Thyroid hormones (thyroxine {T4} and tri-iodothyronine {T3} are extensively protein bound in the
plasma and measurements of total hormone concentrations can give misleading information if the
concentration of binding proteins are abnormal. Measurements of the free ( and physiologically
active) hormones (fT4, fT3, but particularly the former) are now replacing total hormone
measurements.
Measurement of thyroid stimulating hormone (TSH) is valuable since in primary thyroid disease (
which is far commoner than thyroid disease secondary to a pituitary cause), its concentration
inversely reflects thyroid activity.
Reference ranges
TSH 0.3-5.0 mIU/L
Thyroxine (total) 60-150 nmol/LTri-iodothyronine (total) 1.2-2.9 nmol/L
Thyroxine (free) 9.0-26 pmol/L
Tri-iodothyronine (free) 3.0-8.8 pmol/L
28
-
8/13/2019 Clinical Biochemistry Assays
29/29
T3 T4 TSH
Hyperthyroidism
T3Thyrotoxicosis
Thyrotoxicosis
Hypothyroidism
PRACTICAL XIII
RADIONIMMUNOASSAY (RIA) AND ELISA
RIA and ELISA are widely used because these tests are extremely sensitive. RIA and ELISA are methods used for the determination of the concentration of thehormones, glycoproteins, peptide hormones and other hormones.
PRINCIPLE
For both the RIA and ELISA tests, the human antigen is put into a plastic test tube or on a plastic
microtitre plate. Some of the antigen will adsorb to the surface of the tube or plate and the excess is
then washed away. The serum to be tested is added to the tube or plate and incubated for a short
time. If antibodies are present, they will bind the Ag.
For the RIA, the excess Ab is washed away and a radioactively labeled Ag that can react with the Ab
is added. The excess radioactive Ag is washed away and the tubes are then counted using a gamma
counter.
The ELISA is done in a similar manner except instead of using a radioactive Ag, the Ag is coupled
to an enzyme such as peroxidase. The Ag binds to the test Ab, excess ligand is washed away, and
chromogen is added. Chromogen is a colorless substrate that produces a colour end point when acted
upon by an enzyme such as peroxidase. The colour change can then be observed and measured using
a microplate reader.